HeartWare International, Inc. (HeartWare International) confirms that the US Federal Trade Commission (FTC) has informed HeartWare International and Thoratec Corporation (Thoratec) that the FTC will file a complaint in US Federal District Court to challenge Thoratec's proposed acquisition of HeartWare International.
Thoratec and HeartWare International are disappointed with the FTC’s decision to challenge the acquisition. The companies intend to review the FTC’s decision and mutually assess the appropriate next steps and promptly communicate their intentions to the market once a decision has been made.
HeartWare International develops and manufactures miniaturized implantable heart pumps
Thoratec is a company engaged in developing therapies to address advanced-stage heart failure.